Identification of prognostic and diagnostic signatures for cancer and acute myocardial infarction: multi-omics approaches for deciphering heterogeneity to enhance patient management
Patients diagnosed with cancer face an increased risk of cardiovascular events in the short term, while those experiencing acute myocardial infarction (AMI) have a higher incidence of cancer. Given limitations in clinical resources, identifying shared biomarkers offers a cost-effective approach to r...
Main Authors: | Na Yuan, Hai-Hua Pan, Yan-Shan Liang, Hui-Lin Hu, Chang-Lin Zhai, Bo Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1249145/full |
Similar Items
-
Complications in Acute Myocardial Infarction: Navigating Challenges in Diagnosis and Management
by: Errol Moras, et al.
Published: (2024-03-01) -
CUPRAC-Reactive Advanced Glycation End Products as Prognostic Markers of Human Acute Myocardial Infarction
by: Govigerel Bayarsaikhan, et al.
Published: (2021-03-01) -
Malondialdehyde as a marker of lipid peroxidation in acute myocardial infarction patients
by: H D Shilpa, et al.
Published: (2013-01-01) -
Prothrombotic gene variants as risk factors of acute myocardial infarction in young women
by: Tomaiuolo Rossella, et al.
Published: (2012-11-01) -
Novel diagnostic biomarkers related to necroptosis and immune infiltration landscape in acute myocardial infarction
by: Wenfa Wu, et al.
Published: (2024-02-01)